🔎 Trials Near Me

Home › Essential Thrombocythemia › Tennessee › Nashville

Essential Thrombocythemia clinical trials in Nashville, TN

5 studies for Essential Thrombocythemia are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Tristar Bmt/Tcto, Nashville
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07441694

A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

RecruitingPhase 3
  • Vanderbilt University Medical Center, Nashville
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07623200

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

RecruitingPhase 2
  • Vanderbilt University/Ingram Cancer Center, Nashville
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06661915

A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms

RecruitingPhase 1
  • Site US19, Nashville
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07849231

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Vanderbilt University Medical Center, Nashville
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT06034002

Essential Thrombocythemia trials in other cities

Other studies in Nashville

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.